| Amount | Holding |
|---|---|
| 7.28% | Johnson & Johnson |
| 5.38% | Roche Holding AG Dividend Right Cert. |
| 4.75% | UnitedHealth Group Inc |
| 4.69% | Merck & Co Inc |
| 4.47% | Novartis AG |
| 3.76% | Sanofi SA |
| 3.61% | Abbott Laboratories |
| 3.60% | Eli Lilly and Co |
| 3.32% | Medtronic PLC |
| 3.25% | Novo Nordisk A/S ADR |
| 3.10% | Intuitive Surgical Inc |
| 3.06% | Bristol-Myers Squibb Company |
| 2.94% | Thermo Fisher Scientific Inc |
| 2.91% | Zoetis Inc Class A |
| 2.89% | GlaxoSmithKline PLC |
| 2.57% | Vertex Pharmaceuticals Inc |
| 2.40% | CSL Ltd |
| 2.29% | Gilead Sciences Inc |
| 2.26% | Boston Scientific Corp |
| 2.12% | Humana Inc |
| 1.97% | Anthem Inc |
| 1.92% | Pfizer Inc |
| 1.79% | AstraZeneca PLC |
| 1.56% | Edwards Lifesciences Corp |
| 1.28% | Lonza Group Ltd |
Expense Ratio Rating
5 /10
Expense Rating
2 /10
Market Score
5 /10
Category Score
0 /10
Market Size
5 /10
$EIHSX Alternatives
36%
FI Score
- eihsx
- Mutual Fund
- Sector Equity
- Healthcare
Eaton Vance Worldwide Health Sciences Fund Class I
Expenses: 0.84% (Better than 1% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why ยป